title: Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experience.
authors.affiliation: Department of Medicine, Institut Gustave-Roussy, Villejuif/France.
authors.forename: J P
authors.initials: JP
authors.lastname: Droz
authors.forename: M B
authors.initials: MB
authors.lastname: Azab
authors.forename: C
authors.initials: C
authors.lastname: Theodore
authors.forename: M
authors.initials: M
authors.lastname: Ghosn
authors.forename: M
authors.initials: M
authors.lastname: Ostronoff
authors.forename: A
authors.initials: A
authors.lastname: Boutan-Laroze
authors.forename: B H
authors.initials: BH
authors.lastname: Court
authors.forename: J L
authors.initials: JL
authors.lastname: Perrin
authors.forename: J P
authors.initials: JP
authors.lastname: Travagli
authors.forename: P
authors.initials: P
authors.lastname: Wibault
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D015653:Cystectomy; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D014747:Vinblastine; D002945:Cisplatin; D008727:Methotrexate